INCY

Congressional Activity
Incyte Corporation - Common Stock (INCY) [ST]
ARIA INTELLIGENCE BRIEF

Public disclosure records show three members of Congress — Ro Khanna, Daniel Goldman, and Rob Bresnahan — have filed a combined eight trades in this Health Care sector security between March 2023 and May 2025, reflecting a net selling posture of five sales against three purchases. The activity is relatively thin by congressional-trading standards, and no bipartisan co-trading clusters are recorded for this name. Five executive-branch officials have separately disclosed seven transactions in the same security in public filings, though the closest congressional and executive purchases fell 200 days apart, outside the 90-day proximity window used to flag temporal overlap.

Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
8
BUYS
3
SELLS
5
MEMBERS
3
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
+3.70%
vs SPY benchmark
INCY timeline15 trades · Congress + cabinet · convergence
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy  ▼ sell  ◆ n/a  ■ event
CONGRESSCABINETOct 23Apr 24Oct 24Apr 25Oct 25
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
View all on Executive page →
OFFICIALAGENCYDATETYPEAMOUNT
Kumar, Harry
Assistant Secretary of Intergovernmental & Legislative Affairs
Department of Commerce
Jan 23, 26SELL$1K–$15K
Feinberg, Stacey
Dec 30, 25SELL$15K–$50K
Feinberg, Stacey
Dec 30, 25SELL$50K–$100K
Gould, Jonathan
Sep 2, 25SELL$1K–$15K
Danley, Christopher D
Senior Advisor to the Solicitor
Department of the Interior
Jun 6, 25SELL$50K–$100K
Danley, Christopher D
Senior Advisor to the Solicitor
Department of the Interior
Jun 3, 25BUY$50K–$100K
Mcgranahan, John Russell
Russell General Counsel
General Services Administration
Jan 23, 25SELL$1K–$15K
8 trades
Congressional trading data from STOCK Act filings. Not investment advice.
MEMBERS WHO TRADED INCY · 3
Ro Khanna6Daniel Goldman1Rob Bresnahan1